ProPhase Labs, Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
ProPhase Labs, Inc. (PRPH) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $6.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2026-08-19
- ProPhase Labs, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2026-06-30 was $0.00.
- ProPhase Labs, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2026-03-31 was $6.00K.
- ProPhase Labs, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-06-30 was -$823.00K.
- ProPhase Labs, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2024-09-30 was $72.00K.
- ProPhase Labs, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2020 was $1.90M.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-08-19 | $6.00K 10-Q · filed 2026-08-19 | ||
| 2026-03-31 | $6.00K 10-Q/A · filed 2026-07-09 | |||
| 2025-06-30 | -$823.00K 10-Q · filed 2026-08-19 | -$868.00K 10-Q · filed 2026-08-19 | ||
| 2024-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $91.00K 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | $19.00K 10-Q · filed 2024-08-14 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 | |||
| 2020-12-31 | $1.90M 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |